Metzak, Paul D.
Shakeel, Mohammed K.
Long, Xiangyu
Lasby, Mike
Souza, Roberto
Bray, Signe
Goldstein, Benjamin I.
MacQueen, Glenda
Wang, JianLi
Kennedy, Sidney H.
Addington, Jean
Lebel, Catherine
Funding for this research was provided by:
Fondation Brain Canada
Mathison Centre for Mental Health Research and Education
Article History
Received: 29 November 2021
Accepted: 6 July 2022
First Online: 15 September 2022
Declarations
:
: All participants provided informed consent and the study was approved by ethics committees of the University of Calgary (REB 14–1710) and Sunnybrook Health Sciences Centre (REB 100–2015). All methods were performed in accordance with the relevant guidelines and regulations of the ethics committees and in compliance with the Declaration of Helsinki [CitationRef removed].
: Not applicable.
: JA has received research support from National Institute of Mental Health, Brain Canada and the Mathison Centre at the University of Calgary. SHK has received funding or honoraria from the following sources: Abbott, Alkermes, Allergan, AstraZeneca, BMS, Brain Cells Inc., Brain Canada, Clera, CIHR, Eli Lilly, Janssen, Lundbeck, Lundbeck Institute, OMHF, Ontario Brain Institute, Otsuka, Pfizer, Servier, St. Jude Medical, Sunovion and Xian-Janssen. GMM has been on advisory board or speaker for Allergen, Lundbeck, Lilly, Pfizer, Janssen, Johnson & Johnson. PDM, MKS, XL, ML, RS, SB, BIG, JW, and CL report no biomedical financial interests or potential conflicts of interest.